Qing Li

Areas of Specialty

• Diagnosis and treatment of cervical diseases (including cervical inflammatory diseases, HPV infection, precancerous lesions, cervical cancer, and cervical diseases during pregnancy and postmenopause); with particular expertise in fertility-preserving treatment and surgery for cervical lesions;
• Diagnosis and treatment of vulvar pruritus, vulvar squamous epithelial hyperplasia, vulvar lichenification, vulvar/vaginal condyloma acuminata, and benign vulvar/vaginal tumors；
• Diagnosis and treatment of genital tract inflammation and complex vaginitis, as well as regulation of vaginal microecology;
• Consultation, advice, and clinical management of fertility-related issues caused by HPV infection/cervical lesions;
• Consultation on the clinical application of HPV vaccines and formulation of vaccination plans.

Education Background

• 1980.09-1985.07，Graduated from the Medical Department of Shandong First Medical University, obtained a Bachelor of Medicine degree;
• 2001.10-2003.04，Completed the clinical medicine courses at the Postgraduate Program of Huazhong University of Science and Technology;
• 1999.01-1999.10，Conducted visiting studies and training at Renji Hospital Affiliated to Shanghai Jiao Tong University;
• 2006 ，Conducted visiting studies and training at the Colposcopy Center of The Whittington Hospital in London, UK;
• 2007 ，Conducted visiting studies and training at the Colposcopy Center of Montecchio Emilia Hospital (affiliated to Aviano Cancer Hospital) in Italy.

Working Experience

• 1985.07-1990.12，Served as Teaching Assistant/Resident Physician in the Obstetrics and Gynecology Teaching and Research Section of the Medical Department of Shandong First Medical University;
• 1991.01-2022.03 ，Served at Shenzhen Maternity and Child Healthcare Hospital (formerly Shenzhen Women and Children’s Hospital) as Attending Physician, Associate Chief Physician, Chief Physician, and Level-3 Chief Physician in the Department of Obstetrics and Gynecology;
• 2008.05-2013.06，Served as Deputy Director of the Cervical Disease Diagnosis and Treatment Center at Shenzhen Maternity and Child Healthcare Hospital;
• 2013.06-2022.03，Served as Director of the Cervical Disease Department (Fuqiang Gynecology Clinic) at Shenzhen Maternity and Child Healthcare Hospital.

Academic Achievement

• Participated in multiple provincial, municipal, and national-level scientific research projects:
  Clinical gynecologist and obstetrician for the national-level Phase III Clinical Trial of Recombinant Human Papillomavirus (HPV) Type 16/18 Bivalent Vaccine (Escherichia coli) ；
• Participated in the collaborative research and development of the “Artificial Intelligence Electronic Colposcope Assisted Diagnosis System for Cervical Cancer” with the School of Population Medicine and Public Health, Peking Union Medical College；
• Expert of the Endpoint Event Adjudication Committee for Walvax Biotechnology’s “Extended Study on Long-term Protective Efficacy of Bivalent Human Papillomavirus Vaccine (Pichia pastoris)”；
• One of the leaders of the project “Demonstration Base for Early Diagnosis and Treatment of Cervical Cancer” under the Disease Control Bureau of the National Health Commission / China Cancer Foundation；
• Authored the monograph Colposcopic Atlas of Cervical Diseases and co-authored 5 other professional books on colposcopic diagnosis. Published 25 papers as the first author or corresponding author, including:
• Mingyang Chen 1,†, Jiaxu Wang 1,†, Peng Xue 1,* , Qing Li 2, et al. Evaluating the Feasibility of Machine-Learning-Based Predictive Models for Precancerous Cervical Lesions in Patients Referred for Colposcopy. MDPI Diagnostics 2022, 12, 3066. https://doi.org/10.3390/diagnostics12123066
• Mingyang Chen, BM; Peng Xue, PhD; Qing Li, BM, et al. Enhancing colposcopy training using a widely accessible digital education tool in China. American Journal of Obstetrics & Gynecology. July 2023. https://doi.org/10.1016/j.ajog.2023.07.043
• “A Stratified Study on Evaluating the Risk of Cervical Precancerous Lesions Detected by Cytology and HR-HPV in Colposcopy”. Chinese Journal of Disease Control and Prevention 2021 Jul; 25(7)
• “Meta-Analysis of the Diagnostic Value of Colposcopy for Cervical Lesions”. International Journal of Obstetrics and Gynecology (2021)48(2):160-164
• Development and validation of an artificial intelligence system for grading colposcopic impressions and guiding biopsies. BMC Medicine (2020) 18:406

Honors, Awards and Professional Memberships

• Director of the Cervical Disease Department, Shenzhen Maternity and Child Healthcare Hospital Affiliated to Southern Medical University;
• Visiting Professor at the School of Population Medicine and Public Health, Peking Union Medical College;
• Distinguished Professor at the Shenzhen Health Commission Medical Education and Training Center;
• Member of the National Cervical Cancer Prevention and Control Cooperation Group, China Cancer Foundation;
• Member of the Gynecologic Oncology Professional Committee, Shenzhen Medical Doctor Association